Male Hypogonadism – Genitourinary Disorders – Merck …

Posted: July 10, 2016 at 9:41 am

By Irvin H. Hirsch, MD

NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version

NOTE: This is the Professional Version. DOCTORS: Click here for the Consumer Version

Hypogonadism is defined as testosterone deficiency with associated symptoms or signs, deficiency of spermatozoa production, or both. It may result from a disorder of the testes (primary hypogonadism) or of the hypothalamic-pituitary axis (secondary hypogonadism). Both may be congenital or acquired as the result of aging, disease, drugs, or other factors. Additionally, a number of congenital enzyme deficiencies cause varying degrees of target organ androgen resistance. Diagnosis is confirmed by hormone levels. Treatment varies with etiology but typically includes gonadotropin-releasing hormone, gonadotropin, or testosterone replacement.

DELATESTRYL

No US brand name

ZOLADEX

ALDACTONE

REGLAN

TAGAMET

NIZORAL

LUPRON

OZURDEX

NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version

NOTE: This is the Professional Version. DOCTORS: Click here for the Consumer Version

View post:
Male Hypogonadism - Genitourinary Disorders - Merck ...

Related Posts

Comments are closed.

Archives